**Peer Review Journal ** DOI on demand of Author (Charges Apply) ** Fast Review and Publicaton Process ** Free E-Certificate to Each Author

Current Issues
     2026:7/2

International Journal of Multidisciplinary Research and Growth Evaluation

ISSN: (Print) | 2582-7138 (Online) | Impact Factor: 9.54 | Open Access

Comparing the Cost-Effectiveness of Pharmaceutical vs. Non-Pharmaceutical Interventions for Diabetes Management

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF)

Abstract

Diabetes is a major global health concern, requiring effective management strategies to prevent complications and improve patient outcomes. While pharmaceutical interventions, such as insulin therapy and oral hypoglycemic agents, are widely used to regulate blood glucose levels, non-pharmaceutical approaches including lifestyle modifications, behavioral therapy, and alternative treatments have gained attention for their potential long-term benefits. This review compares the cost-effectiveness of pharmaceutical and non-pharmaceutical interventions for diabetes management, evaluating their economic impact, health outcomes, and sustainability. Pharmaceutical interventions are often effective in rapidly lowering blood sugar levels and preventing acute complications. However, they come with high costs, potential side effects, and long-term financial burdens for healthcare systems and patients. In contrast, non-pharmaceutical approaches, such as dietary changes, physical activity, and weight management, offer sustainable, cost-effective benefits by addressing the root causes of diabetes. While lifestyle modifications require significant behavioral changes and patient adherence, they have been shown to reduce medication dependence and lower healthcare costs over time. A comparative analysis reveals that while pharmaceuticals provide immediate and necessary glycemic control, non-pharmaceutical interventions contribute to long-term disease prevention and reduced economic burden. The combination of both strategies often results in the most cost-effective and patient-centered approach. However, challenges such as access to lifestyle programs, patient adherence, and insurance coverage disparities must be addressed to optimize diabetes management. This review highlights the need for healthcare policies that integrate both pharmaceutical and non-pharmaceutical strategies to maximize cost-effectiveness and improve patient outcomes. Future research should focus on personalized treatment models, ensuring that patients receive tailored interventions based on their medical and economic needs. Ultimately, a balanced, multidisciplinary approach is essential for sustainable and effective diabetes management.

How to Cite This Article

Julie Alaere Atta, Mohammad Ahmmad Mahmoud Al Zoubi, Tarilate Temedie-Asogwa, Joy Amafah (2021). Comparing the Cost-Effectiveness of Pharmaceutical vs. Non-Pharmaceutical Interventions for Diabetes Management . International Journal of Multidisciplinary Research and Growth Evaluation (IJMRGE), 2(6), 409-419. DOI: https://doi.org/10.54660/.IJMRGE.2021.2.1-409-419

Share This Article: